NCR3 and gastric cancer: In keeping with what has been observed in PDAC and CRC, a downregulation in the expression of the main NCRs, i.e., NKp30 and NKp46, together with NKG2D and DNAM1 (see below), has been observed in circulating NK cells from GC patients at different stages.